Liver Cirrhosis, Experimental
"Liver Cirrhosis, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.
MeSH Number(s)
C06.552.630.467
E05.598.500.468
Concept/Terms
Liver Cirrhosis, Experimental- Liver Cirrhosis, Experimental
- Cirrhosis, Experimental Liver
- Liver Cirrhoses, Experimental
- Experimental Liver Cirrhosis
- Hepatic Cirrhosis, Experimental
- Experimental Hepatic Cirrhosis
- Cirrhoses, Experimental Liver
- Experimental Liver Cirrhoses
Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis, Experimental".
This graph shows the total number of publications written about "Liver Cirrhosis, Experimental" by people in Harvard Catalyst Profiles by year, and whether "Liver Cirrhosis, Experimental" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 3 |
| 2021 | 1 | 0 | 1 |
Below are the most recent publications written about "Liver Cirrhosis, Experimental" by people in Profiles.
-
Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation/NF-?B inhibition. Int Immunopharmacol. 2021 Nov; 100:108088.
-
Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis. 2020 02 18; 11(2):132.
-
Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Am J Physiol Gastrointest Liver Physiol. 2020 01 01; 318(1):G174-G188.
-
Ablation of Hepatocyte Smad1, Smad5, and Smad8 Causes Severe Tissue Iron Loading and Liver Fibrosis in Mice. Hepatology. 2019 12; 70(6):1986-2002.
-
Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice. Hepatology. 2019 12; 70(6):1972-1985.
-
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology. 2018 09; 68(3):1125-1139.
-
An ?-3-enriched diet alone does not attenuate CCl4-induced hepatic fibrosis. J Nutr Biochem. 2016 12; 38:93-101.
-
Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy. World J Gastroenterol. 2016 May 21; 22(19):4685-94.
-
Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via av integrin interaction. J Gastroenterol. 2016 Dec; 51(12):1161-1174.
-
The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis. J Hepatol. 2016 06; 64(6):1378-87.